Medication Instruction- Oral Antiviral Drug(Molnupiravir) for COVID-19 用藥指導-COVID-19治療口服抗病毒藥品Molnupiravir
2025/3/5
Applicant: To be prescribed to adult patients with mild-to-moderate COVID-19 at high risk of severe disease, aged 18 years of age and older, have not used oxygen therapy and have onset within 5 days. For patients who could not use other recommended drugs.